The U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a disorder that often appears as patchy baldness and affects more than 300,000 people in the U.S. each year. This marks the first FDA approval of a systemic treatment (i.e. treats the entire body rather than a specific location) for alopecia areata. Alopecia areata, commonly referred to as just alopecia, is an autoimmune disorder in which the body attacks its…

Speaking of Women's Health guest columnist Dr. Jessica Ruff shares how acupuncture can help reduce headaches.

AstraZeneca and MSD’s Lynparza (olaparib) has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm) HER2-negative high-risk early breast cancer who have already been treated with chemotherapy either before or after surgery. The approval by the US Food and Drug Administration (FDA) was based on results from the OlympiA Phase III trial presented during the 2021 American Society of Clinical Oncology Annual Meeting and published in The New England…

New study evaluates prevalence of hair loss during the menopause transition and factors contributing to it, including obesity.

Guest columnist Dr. Robert Saper of the Department of Wellness and Preventive Medicine at Cleveland Clinic discusses how studies show that yoga can help women with chronic pain and recurrent pain.

In part 2 of the column series, Updates From the 2021 North American Menopause Society (NAMS) Annual Meeting, Dr. Tara Iyer discusses the latest on cardiovascular disease, breast cancer and cervical cancer risks for menopausal women.

In part 1 of the column series, Updates From the 2021 North American Menopause Society (NAMS) Annual Meeting, Dr. Tara Iyer discusses the latest on weight management, hair loss and sleep problem treatments for menopausal women.

Guest columnist Evelina Vasiliauskas PA-C in the Departments of Dermatology and Plastic Surgery at the Cleveland Clinic shares at-home tips and in-office treatments for improving aging skin.

Read Dr. Holly L. Thacker’s latest column about why you may be feeling extra tired lately and what you can do to help extreme fatigue.

Guest columnists Dr. Fawad Khan and Dr. Holly Pederson discuss the Polygenic Risk Score (PRS) and how these gene changes may affect a person's risk for breast cancer.

Fibroids are usually diagnosed in women ages 30-40, and up to half of all women will be diagnosed with fibroids in their lifetime. Guest columnist Dr. Sharon Sutherland discusses the new FDA-approved medication for the treatment of symptomatic fibroids.

Hair loss in middle-aged females is common, affecting up to two-thirds of women after menopause. The exact reasons remain unclear, although evidence suggests a hormonal and genetic predisposition. A presentation at The North American Menopause Society (NAMS) Annual Meeting in Washington, DC, September 22-25, 2021, will address common hair loss problems and review new therapies and treatment approaches to stimulate hair growth and minimize thinning. There are many different types of…

Guest columnists Alice Bast, CEO of Beyond Celiac and Alan Ehrlich, MD, Board Chair of Beyond Celiac discuss celiac disease and how it affects women's health.

Toddlers who were breastfed for any amount of time had lower blood pressure than those who were not breastfed at all, according to a new study, suggesting once again that "breast is best" for health. The reduction in blood pressure found in the study "is of clinically important magnitude and surprising," Dr. Lori Feldman-Winter told CNN in an email. Feldman-Winter, who was not involved in the study, is the chair of the American Academy of Pediatrics Section on Breastfeeding. "I may have…

Key takeaways: Myfembree (relugolix/estradiol/norethindrone acetate) was recently FDA-approved to treat heavy monthly bleeding due to uterine fibroids — the first once-daily oral medication to treat this condition.Myfembree was very effective in clinical trials and helped lighten bleeding for over 70% of people taking it. Myfembree can cause bone loss, so you should only take it for a total of two years to avoid serious bone problems like osteoporosis.Myfembree is currently available at…

Dr. Holly L. Thacker shares tips for the best ways to protect your skin from the sun and what you really need to know about sunscreens.

If you are approaching menopause and you have some extra belly fat, new research suggests you might want to shed some inches now. Women who carry weight around their midsection during menopause may be more likely to develop heart disease even if their overall weight remains the same, researchers report. For every 20% increase in belly fat, the thickness of the carotid artery lining grew by 2%, according to their study. The carotid arteries carry blood to the head and neck, and carotid artery…

Dr. Holly L. Thacker discusses the three stages of menopause and how women can know when they are entering each menopause stage.

Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints Primary efficacy analysis demonstrates BNT162b2 to be 95% effective against COVID-19 beginning 28 days after the first dose; 170 confirmed cases of COVID-19 were evaluated, with 162 observed in the placebo group versus 8 in the vaccine groupEfficacy was consistent across age, gender, race and ethnicity demographics; observed efficacy in adults over 65 years of age was…

Dr. Howard Tay shares treatment options for women suffering from dyspareunia and pain with sexual activities.